.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Baxter
Teva
AstraZeneca
QuintilesIMS
Express Scripts
UBS
Federal Trade Commission
US Army
Healthtrust

Generated: June 28, 2017

DrugPatentWatch Database Preview

PHENOXYBENZAMINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Phenoxybenzamine Hydrochloride, and what generic Phenoxybenzamine Hydrochloride alternatives are available?

Phenoxybenzamine Hydrochloride is a drug marketed by Par Pharm Inc and West-ward Pharms Int and is included in two NDAs.

The generic ingredient in PHENOXYBENZAMINE HYDROCHLORIDE is phenoxybenzamine hydrochloride. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the phenoxybenzamine hydrochloride profile page.

Summary for Tradename: PHENOXYBENZAMINE HYDROCHLORIDE

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list49
Clinical Trials: see list2,250
Patent Applications: see list444
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PHENOXYBENZAMINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: PHENOXYBENZAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm Inc
PHENOXYBENZAMINE HYDROCHLORIDE
phenoxybenzamine hydrochloride
CAPSULE;ORAL204522-001Jan 24, 2017ABRXNoNo► Subscribe► Subscribe
West-ward Pharms Int
PHENOXYBENZAMINE HYDROCHLORIDE
phenoxybenzamine hydrochloride
CAPSULE;ORAL201050-001Jul 16, 2012ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Federal Trade Commission
Citi
Accenture
Johnson and Johnson
Teva
Argus Health
Fuji
Chinese Patent Office
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot